by [email protected] | Dec 9, 2022 | Publication, Pulmonary
Abstract BACKGROUND: Asthma is a common chronic respiratory disorder associated with significant disease and economic burden. Mepolizumab is an anti-IL-5 mAb approved for use as an add-on treatment in patients with severe eosinophilic asthma. OBJECTIVE: To assess the...
by [email protected] | Dec 9, 2022 | Cardiovascular, Publication
Abstract Background: Oral anticoagulants (OACs) mitigate stroke and systemic embolism (SE) risk in non-valvular atrial fibrillation (AF) patients but can increase the risk of major bleeding (MB). This study analyzed the gains in event-free time for these...
by [email protected] | Dec 9, 2022 | Cardiovascular, Publication
Abstract This study evaluated effectiveness and safety of apixaban versus warfarin among venous thromboembolism patients at high-risk of bleeding (defined as having at least one of the following bleeding risk factors: ≥75 years; used antiplatelet, NSAIDs, or...
by [email protected] | Dec 9, 2022 | Cardiovascular, Publication
Abstract Importance: The CHA2DS2-VASc score (calculated as congestive heart failure, hypertension, age 75 years and older, diabetes, stroke or TIA, vascular disease, age 65 to 74 years, and sex category) is the standard for assessing risk of stroke and systemic...
by [email protected] | Nov 21, 2022 | News & Events
STATinMED is proudly participating in the upcoming American Society of Hematology 64th Annual Meeting held in New Orleans, LA, Dec 10-13, 2022. 2 abstract accepted for presentation Presentations A US national view of prevalent and newly diagnosed multiple myeloma in...
